欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	MT/H/0413/002
药品名称	Haloperidol Thame 1mg/ml Oral Solution
活性成分	haloperidol 200.0 µg/ml
剂型	Oral solution
上市许可持有人	Syri Pharma Limited 1 Windmill Lane Dublin 2 Co. Dublin D02 F206 Ireland
参考成员国 - 产品名称	Malta (MT)
互认成员国 - 产品名称	United Kingdom (Northern Ireland) (XI) Thamidol 5mg/5ml Oral Solution
许可日期	2016/12/20
最近更新日期	2023/10/09
药物ATC编码	N05AD01 haloperidol
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载	Final Product Information \| common_impack_1mg_ml_cleanDate of last change:2022/09/01 Final Product Information \| common_outer_1mg_ml_cleanDate of last change:2022/09/01 Final Product Information \| common_pl_200mcg_ml_cleanDate of last change:2022/09/01 Final Product Information \| common_outer_200mcg_ml_cleanDate of last change:2022/09/01 Final Product Information \| common_impack_200mcg_ml_cleanDate of last change:2022/09/01 Final Product Information \| common_spc_200mcg_ml_cleanDate of last change:2022/09/01 Final PL \| MT_H_0436 m1-3-1-mt-pl-cleanDate of last change:2020/02/28 Final PL \| MT_H_0428 m1-3-1-mt-pl-7-5mg-5ml-cleanDate of last change:2020/02/28 Final PL \| MT_H_0396_001_PLDate of last change:2020/02/28 Final PL \| MT_H_0405 m1-3-1-mt-pl-cleanDate of last change:2020/02/28 Final PL \| MT_H_0428 m1-3-1-mt-pl-30mg-5ml-cleanDate of last change:2020/02/28 Final PL \| MTH0424_common_pl_clean MT_H_xxxx_1A_025_GDate of last change:2020/02/28 Final PL \| MTH0413_001_common_pl_clean MT_H_xxxx_1A_025_GDate of last change:2020/02/28 Final PL \| MTH0413_002_common_pl_clean MT_H_xxxx_1A_025_GDate of last change:2020/02/28 Final PL \| PL129601201Date of last change:2020/02/28 Final PL \| PL MTH0358 V011G - MTHxxxx1A_025GDate of last change:2020/02/28 Final PL \| PL129600801Date of last change:2020/02/28 Final PL \| PL129601301Date of last change:2020/02/28 Final PL \| PL129602301Date of last change:2020/02/28
市场状态	Positive